Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial …
There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week …
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but did not rattle our investment thesis in the …
With obesity rates rising in Canada and globally, new research suggests there is a higher risk of stillbirth in mothers with obesity. Experts say early delivery could help minimize those …
More than one billion people worldwide are grappling with obesity, with children in particular experiencing alarming increases in numbers, a new study shows. A global analysis published in the Lancet …
Rates of obesity have leveled off in some wealthy countries – particularly in Europe. Effective, popular obesity medications won’t be enough to solve a worldwide problem that now affects more …
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan Mcdermid | Reuters For all of the promise associated …
Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag â typically between $1,000 …
Evercore ISI’s Julian Emanuel thinks Nvidia’s monster rally is fueling a fear of missing out in the market. He finds clients, including many who traded through the dot-com boom and …
As the winter blues set in for many in Canada, experts say feelings of depression can lead people to gain weight, with new research suggesting that the risk of weight …